NasdaqCM - Delayed Quote USD
Nexalin Technology, Inc. (NXL)
At close: November 22 at 4:00 PM EST
After hours: 7:34 PM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Mark White | President, CEO, CFO & Director | 442.5k | -- | 1962 |
| Dr. David Owens M.D. | Chief Medical Officer & Director | 42.8k | -- | 1962 |
| Ms. Marilyn Elson | Controller | 382.72k | -- | 1953 |
| Mr. John Patrick Claude | Co-Founder and Director of Engineering & Development | -- | -- | -- |
| Ms. Carolyn Shelton | Senior Vice President of Quality, Regulatory & Clinical Affairs | -- | -- | 1962 |
Nexalin Technology, Inc.
- Sector:?
- Healthcare
- Industry:? Medical Devices
- Full Time Employees:?
- 6
Description
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.
Corporate Governance
Nexalin Technology, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Related Tickers
BSGM BioSig Technologies, Inc.
2.0000
+3.63%
AMIX Autonomix Medical, Inc.
6.28
-53.55%
NUWE Nuwellis, Inc.
1.2100
-2.42%
BJDX Bluejay Diagnostics, Inc.
3.5200
+0.57%
SINT Sintx Technologies, Inc.
4.9600
+15.35%
SRTS Sensus Healthcare, Inc.
8.89
-0.45%
BBLG Bone Biologics Corporation
1.2500
+1.63%
IINN Inspira Technologies Oxy B.H.N. Ltd.
1.3600
+0.74%
QSI Quantum-Si incorporated
1.6200
+33.88%
TMDX TransMedics Group, Inc.
76.04
-4.16%